• Fremanezumab for the Treatment of Migraine and Major Depressive Disorder

  • May 5 2025
  • Length: 21 mins
  • Podcast

Fremanezumab for the Treatment of Migraine and Major Depressive Disorder

  • Summary

  • Interview with Richard B. Lipton, MD, author of Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder. Hosted by Cynthia E. Armand, MD.

    Related Content:

    • Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder
    Show More Show Less
activate_mytile_page_redirect_t1

What listeners say about Fremanezumab for the Treatment of Migraine and Major Depressive Disorder

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.